Stanevich, O. V., Fomina, D. S., Bakulin, I. G., Galeev, S. I., Bakin, E. A., Belash, V. A., . . . Moiseev, I. S. (2021). Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: Multicenter matched cohort study. BMC infectious diseases, 21(1), 1277-9. https://doi.org/10.1186/s12879-021-06982-z
Chicago-Zitierstil (17. Ausg.)Stanevich, O. V., et al. "Ruxolitinib Versus Dexamethasone in Hospitalized Adults with COVID-19: Multicenter Matched Cohort Study." BMC Infectious Diseases 21, no. 1 (2021): 1277-9. https://doi.org/10.1186/s12879-021-06982-z.
MLA-Zitierstil (9. Ausg.)Stanevich, O. V., et al. "Ruxolitinib Versus Dexamethasone in Hospitalized Adults with COVID-19: Multicenter Matched Cohort Study." BMC Infectious Diseases, vol. 21, no. 1, 2021, pp. 1277-9, https://doi.org/10.1186/s12879-021-06982-z.